glp-1 news oct 16 2025 trends 2025: real-world data, patient outcomes & future therapies The GLP-1 Access Gap: Mapping
Description
Sales were modest, and by 2017 GSK decided to withdraw albiglutide from the market for commercial reasons
Rich data outputs: Detailed measurements, estimated weight and BMI, and a 3D avatar that updates with every scan
Your fat tissue isnt sitting quietly in storage
Although cholecystitis has been reported, large outcome trials have not substantiated pancreatitis signals, and current evidence does not indicate increased risks of infection or obesity-related cancers
Studies suggest positive changes to gut microbiota in as little as eight weeks
[DOI] [PubMed] [Google Scholar] 10.Tchang B.G., Saunders K.H., Igel L.I
